Applications in aesthetics are off-label
A pesar de ello, la especialista en obesidad de Yale, Ania Jastreboff , calific los resultados como resultados muy impresionantes, sin duda, aunque advirti que el verdadero valor teraputico debe medirse en funcin de los efectos sobre la salud de una persona a lo largo de su vida
SGLT2 Emerging Data and New Head-to-Head Findings (2025-2026) (47) MASLD (Fatty Liver) and T2D: A 2026 study found GLP-1 RAs (e.g., semaglutide) associated with a 14% lower risk of cardiovascular events (MACCE) compared to SGLT2i in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
If you have been losing steadily, they want to protect that momentum as you go through the transition
Every month you wait is a month you could have spent losing weight, lowering your blood pressure, and regaining your energy